Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 2759 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

Cell Therapeutics files sBLA for lymphoma drug

If approved, Zevalin would be the only radioimmunotherapy in the US with approval for use as first-line consolidation therapy. The company has requested priority review, which if granted,